Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Parker enters fiscal 2027 with strong operating momentum: fiscal 2026 organic growth was 6.6%, adjusted segment operating margin reached 27.3%, adjusted EPS increased to $32.31, and backlog reached $12.8 billion. Management guides to further organic growth, margin expansion and adjusted EPS growth in fiscal 2027 and targets a 30% adjusted segment margin by fiscal 2031. The offset is execution and financing risk following the $9.25 billion Filtration Group acquisition, funded primarily with $7.75 billion of term borrowings, alongside the pending CIRCOR Aerospace transaction.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets23 analysts · as of 18 Aug 2026
Low · most bearish analyst$680.00
Mean target$1,160.95
High · most bullish analyst$1,358.00
Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$680.0020%

Organic growth or adjusted margin falls below the lower end of fiscal 2027 guidance as industrial demand, tariffs, supply constraints or unfavorable mix weaken results. Filtration Group integration takes longer or costs more than anticipated, synergy delivery slips, and acquisition-funded leverage reduces financial flexibility.

Base CaseCentral scenario
$1,160.9553%
Matches the consensus mean

Parker performs within its fiscal 2027 guidance ranges, with industrial recovery and aerospace strength supporting growth while acquisition integration and higher financing requirements limit the pace of upside. Filtration Group is accretive for the full fiscal year and synergy realization remains broadly on schedule.

Bull CaseUpside scenario
$1,358.0027%

Parker reaches the upper portions of its fiscal 2027 organic-growth, adjusted-margin and adjusted-EPS guidance; strong aerospace demand and record backlog convert into revenue; and Filtration Group contributes approximately $1.8 billion of fiscal 2027 sales while progressing toward $220 million of pre-tax cost synergies. Sustained execution makes the 30% fiscal 2031 adjusted segment-margin target credible.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Fiscal 2026 delivered 6.6% organic sales growth, 27.3% adjusted segment operating margin and $32.31 adjusted EPS, followed by fiscal 2027 guidance for further growth and margin expansion.
  • Backlog reached a record $12.8 billion at June 30, 2026, including $8.5 billion in Aerospace Systems, with approximately 70% of total backlog scheduled for delivery in the following twelve months.
  • Filtration Group expands Parker's filtration and aftermarket exposure, is expected to contribute approximately $1.8 billion of fiscal 2027 sales and carries an estimated $220 million three-year pre-tax cost-synergy opportunity.
Sign in / Sign up to read more
Key Investment Risks
  • The $9.25 billion Filtration Group acquisition was funded primarily with $7.75 billion of term borrowings, materially increasing integration, refinancing and leverage-management demands.
  • Parker identifies macroeconomic volatility, tariffs and trade restrictions, currency movements, raw-material and critical-component supply constraints, acquisition integration and aerospace product-liability exposure as material risks.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.